7-50470140-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001082971.2(DDC):c.1073G>A(p.Arg358His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
DDC
NM_001082971.2 missense
NM_001082971.2 missense
Scores
14
4
1
Clinical Significance
Conservation
PhyloP100: 7.30
Genes affected
DDC (HGNC:2719): (dopa decarboxylase) The encoded protein catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. Defects in this gene are the cause of aromatic L-amino-acid decarboxylase deficiency (AADCD). AADCD deficiency is an inborn error in neurotransmitter metabolism that leads to combined serotonin and catecholamine deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
PP5
Variant 7-50470140-C-T is Pathogenic according to our data. Variant chr7-50470140-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 379626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDC | NM_001082971.2 | c.1073G>A | p.Arg358His | missense_variant | 12/15 | ENST00000444124.7 | NP_001076440.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDC | ENST00000444124.7 | c.1073G>A | p.Arg358His | missense_variant | 12/15 | 1 | NM_001082971.2 | ENSP00000403644 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251392Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135876
GnomAD3 exomes
AF:
AC:
2
AN:
251392
Hom.:
AF XY:
AC XY:
1
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461044Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726912
GnomAD4 exome
AF:
AC:
9
AN:
1461044
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
726912
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Deficiency of aromatic-L-amino-acid decarboxylase Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 17, 2016 | The NM_001082971.1(DDC):c.1073G>A in exon 12 of the DDC gene is predicted to create a change of an arginine to an histidine at amino acid position 358, NP_001076440.1(DDC):p.p.(Arg358His), which is considered not significant. The arginine at this position has very highly conservation but however, Grantham assessment (A-GVGD) is unlikely pathogenic. In silico software predicts this variant to be disease causing. It is situated in a Pyridoxal phosphate-dependent decarboxylase conserved domain. This variant has not been previously observed in our cohort but is present in a population database at a frequency of 0.002%. It has been previously reported in compound heterozygous state in a patient with aromatic -L-amino decarboxylase deficiency (AADC) and functional studies showed reduced enzyme activity (Verbeek MM. et al.,2007). Based on current information, and in association with the NM_001082971.1(DDC):c.1352G>T variant, this variant has been classified as LIKELY PATHOGENIC. The presence of these two variants suggests a possible compound heterozygous mode of inheritance which is consistent with AADC. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | Experimental studies have shown that this missense change affects DDC function (PMID: 29356298). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DDC protein function. ClinVar contains an entry for this variant (Variation ID: 379626). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 358 of the DDC protein (p.Arg358His). This variant is present in population databases (rs771317809, gnomAD 0.003%). This missense change has been observed in individual(s) with DDC-related conditions (PMID: 17240182, 32369189). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2015 | The R358H variant in the DDC gene has been reported previously in association with AADC deficiency,in an affected individual who was compound heterozygous for the R358H variant and another loss offunction variant. This individual's plasma AADC activity was significantly reduced as compared tonormal AADC activity (Verbeek et al., 2007). The R358H substitution was not observed in approximately6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The R358H variant is a conservativechange at a position that is conserved across species. In silico analysis predicts this variant is probablydamaging to the protein structure/function. A missense variant in a nearby residue (R347Q) has beenreported in the Human Gene Mutation Database in association with AADC deficiency (Stenson et al.,2014), supporting the functional importance of this region of the protein. We interpret R358H as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;.;T;.;.;.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D;D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;.;.;.;.;.;H
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.;.;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;.;.;.;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D
Polyphen
D;.;.;.;.;.;D
Vest4
MutPred
Loss of MoRF binding (P = 0.0412);.;.;.;.;.;Loss of MoRF binding (P = 0.0412);
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at